Clofazimine in the treatment of discoid lupus erythematosus

British Journal of Dermatology

Volumn 91, Issue 1, 1974, Pages 93-96

  MACKEY, J P ^a   BARNES, J ^a  

^a MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; CLOFAZIMINE; IMMUNOSUPPRESSIVE AGENT;

AUTOIMMUNE DISEASE; CHEMOTHERAPY; DISCOID LUPUS ERYTHEMATOSUS; DRUG ADMINISTRATION; DRUG COMPARISON; DRUG THERAPY; PHARMACOLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS; THERAPY;

ADIPOSE TISSUE; ADOLESCENT; ADULT; AGED; CLOFAZIMINE; FEMALE; HUMAN; IMMUNOSUPPRESSION; LUPUS ERYTHEMATOSUS, DISCOID; MACROPHAGES; MALE; MIDDLE AGE; PIGMENTATION; REMISSION, SPONTANEOUS; SEASONS;

EID: 0016200462     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.1974.tb06723.x     Document Type: Article

References (14)

1. A new series of phenazines, with high antituberculosis activity
2. 3‐substituted anilinoaposafranines (rimino‐compounds) and some derivatives
3. The antimycobacterial activity of B.663
4. Rimino‐phenazines and the reticuloendothelial system
5. The antileprosy agent B.663 (clofazimine) and the reticuloendothelial system
6. Uptake by reticuloendothelial cells of the rimino‐phenazine B.663 (2‐p‐chloroanilino‐5‐p‐chlorophenyl‐3,5‐dihydro‐3‐isopropylimino‐phenazine)
7. Management of discoid and systemic lupus erythematosus
8. The relationship of discoid and systemic lupus erythematosus
9. G.30 320 or B663 Lampren (Geigy), a working party
10. A treatment of corticosteroid‐dependent lepromatous patients in persistent erythema nodosum leprosum: a clinical evaluation of G 30 320 (B663)
11. Treatment of chronic discoid lupus erythematosus with chloroquine (Aralen)
12. Lupus erythematosus, scleroderma, dermatomyositis, polyarteritis
13. Effects of RES blockade on antibody formation. I. Suppressed cellular and humoral haemolysin responses in mice. injected with carbon particles
14. Antimalarial effect of B.663 in mice infected with Plasmodium berghei